Role of gut microbiota on cardio-metabolic parameters and immunity in coronary artery disease patients with and without type-2 diabetes mellitus

Frontiers in Microbiology

Volumn 8, Issue OCT, 2017, Pages

  Sanchez Alcoholado, Lidia ^a   Castellano Castillo, Daniel ^a,b   Jordán Martínez, Laura ^a   Moreno Indias, Isabel ^a,b   Cardila Cruz, Pilar ^a   Elena, Daniel ^a   Muñoz Garcia, Antonio J ^a   Queipo Ortuño, Maria I ^a,b   Jimenez Navarro, Manuel ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

Author keywords

Anti inflammatory IL 10; Coronary artery disease; Factor Forkhead box P3; Gut microbiota; Gut permeability increase; TMAO production; Type 2 diabetes mellitus; Zonulin levels

Indexed keywords

BACTERIAL DNA; DNA 16S; MESSENGER RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXP3; TRIMETHYLAMINE OXIDE;

ANTHROPOMETRY; ARTICLE; BACTEROIDES FRAGILIS; BACTEROIDETES; BIOCHEMICAL ANALYSIS; BIOINFORMATICS; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DNA SEQUENCE; DYSLIPIDEMIA; ENTEROBACTERIACEAE; FAECALIBACTERIUM PRAUSNITZII; FIRMICUTES; GENE AMPLIFICATION; GENE CONTROL; GENE EXPRESSION; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; INTESTINE FLORA; METABOLIC PARAMETERS; METAGENOME; MICROBIAL COMMUNITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OPPORTUNISTIC INFECTION; PROTEOBACTERIA; PYROSEQUENCING; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SERUM;

EID: 85030627953     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2017.01936     Document Type: Article

References (47)

1. Aronson, D., and Edelman, E. R. (2016). Coronary artery disease and diabetes mellitus. Heart Fail. Clin. 12, 117-133.
2. Bhute, S., Pande, P., Shetty, S. A., Shelar, R., Mane, S., Kumbhare, S. V., et al. (2016). Molecular characterization and meta-analysis of gut microbial communities illustrate enrichment of prevotella and Megasphaera in Indian subjects. Front. Microbiol. 7:660. doi: 10.3389/fmicb.2016.00660
3. Caligiuri, G., Rudling, M., Ollivier, V., Jacob, M. P., Michel, J. B., Hansson, G. K., et al. (2003). Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice. Mol. Med. 9, 10-17.
4. Craciun, S., and Balskus, E. P. (2012). Microbial conversion of choline to trimethylamine requires a glycyl radical enzyme. Proc. Natl. Acad. Sci. U.S.A. 109, 21307-21312. doi: 10.1073/pnas.1215689109
5. Cui, L., Zhao, T., Hu, H., Zhang, W., and Hua, X. (2017). Association study of gut flora in coronary heart disease through high-throughput sequencing. Biomed. Res. Int. 2017:3796359. doi: 10.1155/2017/3796359
6. De Filippis, F., La Storia, A., Villani, F., and Ercolini, D. (2013). Exploring the sources of bacterial spoilers in beefsteaks by culture-independent high-throughput sequencing. PLOS ONE 8:e70222. doi: 10.1371/journal.pone.0070222
7. Embade, N., Mariño, Z., Diercks, T., Cano, A., Lens, S., and Cabrera, D. (2016). Metabolic characterization of advanced liver fibrosis in HCV patients as studied by serum 1H-NMR spectroscopy. PLOS ONE 11:e0155094. doi: 10.1371/journal.pone.0155094
8. Emoto, T., Yamashita, T., Kobayashi, T., Sasaki, N., Hirota, Y., Hayashi, T., et al. (2017). Characterization of gut microbiota profiles in coronary artery disease patients using data mining analysis of terminal restriction fragment length polymorphism: gut microbiota could be a diagnostic marker of coronary artery disease. Heart Vessels 32, 39-46. doi: 10.1007/s00380-016-0841-y
9. Emoto, T., Yamashita, T., Sasaki, N., Hirota, Y., Hayashi, T., So, A., et al. (2016). Analysis of gut microbiota in coronary artery disease patients: a possible link between gut microbiota and coronary artery disease. J. Atheroscler. Thromb. 23, 908-921. doi: 10.5551/jat.32672
10. Fagerberg, B., Ryndel, M., Kjelldahl, J., Akyürek, L. M., Rosengren, L., Karlström, L., et al. (2010). Differences in lesion severity and cellular composition between in vivo assessed upstream and downstream sides of human symptomatic carotid atherosclerotic plaques. J. Vasc. Res. 47, 221-230. doi: 10.1159/000255965
11. Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., et al. (2013). Commensal microbe derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504, 446-450. doi: 10.1038/nature12721
12. Gao, X., Liu, X., Xu, J., Xue, C., Xue, Y., and Wang, Y. (2014). Dietary trimethylamine N-oxide exacerbates impaired glucose tolerance in mice fed a high fat diet. J. Biosci. Bioeng. 118, 476-481. doi: 10.1016/j.jbiosc.2014.03.001
13. Hasib, L., Lundberg, A. K., Zachrisson, H., Ernerudh, J., and Jonasson, L. (2016). Functional and homeostatic defects of regulatory T cells in patients with coronary artery disease. J. Intern. Med. 279, 63-77. doi: 10.1111/joim.12398
14. Hölscher, M. E., Bode, C., and Bugger, H. (2016). Diabetic cardiomyopathy: does the type of diabetes matter? Int. J. Mol. Sci. 17:E2136. doi: 10.3390/ijms17122136
15. Ikonomidis, I., Andreotti, F., Economou, E., Stefanadis, C., Toutouzas, P., and Nihoyannopoulos, P. (1999). Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by Aspirin. Circulation 100, 793-798.
16. Kim, Y., Keogh, J., and Clifton, P. (2015). A review of potential metabolic etiologies of the observed association between red meat consumption and development of type 2 diabetes mellitus. Metabolism 64, 768-779. doi: 10.1016/j.metabol.2015.03.008
17. Koeth, R. A., Levison, B. S., Culley, M. K., Buffa, J. A., Wang, Z., Gregory, J. C., et al. (2014). L-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO. Cell Metab. 20, 799-812. doi: 10.1016/j.cmet.2014.10.006
18. Koeth, R. A., Wang, Z., Levison, B. S., Buffa, J. A., Org, E., Sheehy, B. T., et al. (2013). Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat. Med. 19, 576-585. doi: 10.1038/nm.3145
19. Konieczna, P., Groeger, D., Ziegler, M., Frei, R., Ferstl, R., Shanahan, F., et al. (2012). Bifidobacterium infantis 35624 administration induces Foxp3 T regulatory cells in human peripheral blood: potential role for myeloid and plasmacytoid dendritic cells. Gut 61, 354-366. doi: 10.1136/gutjnl-2011-300936
20. Koren, O., Spor, A., Felin, J., Fåk, F., Stombaugh, J., Tremaroli, V., et al. (2011). Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc. Natl. Acad. Sci. U.S.A. 108, 4592-4598. doi: 10.1073/pnas.1011383107
21. Li, C., Gao, M., Zhang, W., Chen, C., Zhou, F., Hu, Z., et al. (2016). Zonulin regulates intestinal permeability and facilitates enteric bacteria permeation in coronary artery disease. Sci. Rep. 6:29142. doi: 10.1038/srep29142
22. Lohman, T. G., Roche, A. F., and Martorell, R. (1988). Anthropometric Standardization Reference Manual. Champaign, IL: Human Kinetics Books.
23. Mazmanian, S. K., Round, J. L., and Kasper, D. L. (2008). A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453, 620-625. doi: 10.1038/nature07008
24. McHardy, I. H., Li, X., Tong, M., Ruegger, P., Jacobs, J., and Borneman, J. (2013). HIV Infection is associated with compositional and functional shifts in the rectal mucosal microbiota. Microbiome 1:26. doi: 10.1186/2049-2618-1-26
25. Min, X., Lu, M., Tu, S., Wang, X., Zhou, C., Wang, S., et al. (2017). Serum cytokine profile in relation to the severity of coronary artery disease. Biomed. Res. Int. 2017:4013685. doi: 10.1155/2017/4013685
26. Moreno-Indias, I., Torres, M., Montserrat, J. M., Sanchez-Alcoholado, L., Cardona, F., Tinahones, F. J., et al. (2015). Intermittent hypoxia alters gut microbiota diversity in a mouse model of sleep apnoea. Eur. Respir. J. 45, 1055-1065. doi: 10.1183/09031936.00184314
27. Org, E., Mehrabian, M., and Lusis, A. J. (2015). Unraveling the environmental and genetic interactions in atherosclerosis: central role of the gut microbiota. Atherosclerosis 241, 387-399. doi: 10.1016/j.atherosclerosis.2015.05.035
28. Pereira, L. M. S., Gomes, S. T. M., Ishak, R., and Vallinoto, A. C. R. (2017). Regulatory T cell and forkhead box protein 3 as modulators of immune homeostasis. Front. Immunol. 8:605. doi: 10.3389/fimmu.2017.00605
29. Qiao, Y. C., Shen, J., He, L., Hong, X. Z., Tian, F., Pan, Y. H., et al. (2016). Changes of regulatory T cells and of proinflammatory and immunosuppressive cytokines in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. J. Diabetes. Res. 2016, 3694957.
30. Round, J. L., and Mazmanian, S. K. (2010). Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc. Natl. Acad. Sci. U.S.A. 107, 12204-12209. doi: 10.1073/pnas.0909122107
31. Serino, M., Blasco-Baque, V., Nicolas, S., and Burcelin, R. (2014). Far from the eyes, close to the heart: dysbiosis of gut microbiota and cardiovascular consequences. Curr. Cardiol. Rep. 16:540. doi: 10.1007/s11886-014-0540-1
32. Sitaraman, R. (2013). Phospholipid catabolism by gut microbiota and the risk of cardiovascular disease. J. Med. Microbiol. 62, 948-950.
33. Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., et al. (2013). The microbial metabolites, short chain fatty acids, regulate colonic Treg cell homeostasis. Science 341, 569-573. doi: 10.1126/science.1241165
34. Stremmel, W., Schmidt, K. V., Schuhmann, V., Kratzer, F., Garbade, S. F., Langhans, C. D., et al. (2017). Blood Trimethylamine-N-Oxide originates from microbiota mediated breakdown of phosphatidylcholine and absorption from small intestine. PLOS ONE 12:e0170742. doi: 10.1371/journal.pone.0170742
35. Tang, W. H., and Hazen, S. L. (2014). The contributory role of gut microbiota in cardiovascular disease. J. Clin. Invest. 124, 4204-4211. doi: 10.1172/JCI72331
36. Tang, W. H., Wang, Z., Fan, Y., Levison, B., Hazen, J. E., Donahue, L. M., et al. (2014). Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis. J. Am. Coll. Cardiol. 64, 1908-1914. doi: 10.1016/j.jacc.2014.02.617
37. Tang, W. H., Wang, Z., Levison, B. S., Koeth, R. A., Britt, E. B., Fu, X., et al. (2013). Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N. Engl. J. Med. 368, 1575-1584. doi: 10.1056/NEJMoa1109400
38. Tang, W. H., Wang, Z., Shrestha, K., Borowski, A. G., Wu, Y., Troughton, R. W., et al. (2015). Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure. J. Card. Fail. 21, 91-96. doi: 10.1016/j.cardfail.2014.11.006
39. Tremaroli, V., and Backhed, F. (2012). Functional interactions between the gut microbiota and host metabolism. Nature 489, 242-249. doi: 10.1038/nature11552
40. Troseid, M., Ueland, T., Hov, J. R., Svardal, A., Gregersen, I., Dahl, C. P., et al. (2015). Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure. J. Intern. Med. 277, 717-726. doi: 10.1111/joim.12328
41. Ufnal, M., and Pham, K. (2017). The gut-blood barrier permeability-A new marker in cardiovascular and metabolic diseases? Med. Hypotheses 98, 35-37. doi: 10.1016/j.mehy.2016.11.012
42. Ufnal, M., Zadlo, A., and Ostaszewski, R. (2015). TMAO: a small molecule of great expectations. Nutrition 31, 1317-1323. doi: 10.1016/j.nut.2015.05.006
43. Van Tassell, B. W., Toldo, S., Mezzaroma, E., and Abbate, A. (2013). Targeting interleukin-1 in heart disease. Circulation 128, 1910-1923.
44. Wang, Q., Fang, C. H., and Hasselgren, P. O. (2001). Intestinal permeability is reduced and IL-10 levels are increased in septic IL-6 knockout mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281, R1013-R1023.
45. Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., Dugar, B., et al. (2011). Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472, 57-63. doi: 10.1038/nature09922
46. Wang, Z., Tang, W. H., Buffa, J. A., Fu, X., Britt, E. B., Koeth, R. A., et al. (2014). Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide. Eur. Heart. J. 35, 904-910. doi: 10.1093/eurheartj/ehu002
47. Zhu, Y., Jameson, E., Crosatti, M., Schafer, H., Rajakumar, K., Bugg, T. D., et al. (2014). Carnitine metabolism to trimethylamine by an unusual Rieske-type oxygenase from human microbiota. Proc. Natl. Acad. Sci. U.S.A. 111, 4268-4273. doi: 10.1073/pnas.1316569111